Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Medication withdrawal in relapsing-remitting multiple sclerosis: why not?
Corticosteroids provoke acute endothelial injury - an ideal ground for thrombosis in multiple sclerosis.
The occurrence of dystonia in upper-limb multiple sclerosis tremor.
Asymptomatic Progressive Multifocal Leukoencephalopathy Associated with Natalizumab: Diagnostic Precision with MR Imaging.
Plasma chemerin levels in patients with multiple sclerosis.
Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats.
Neuropsychological Aspects of Childhood Multiple Sclerosis: An Overview.
Accelerated repair of demyelinated CNS lesions in the absence of non-muscle myosin IIB.
DMDs Are an Essential Issue But Are They the Only Issue in MS Treatment?
Mast cells: an expanding pathophysiological role from allergy to other disorders.
In Active Relapsing-Remitting Multiple Sclerosis, Effector T Cell Resistance to Adaptive Tregs Involves IL-6-Mediated Signaling.
The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study.
T-cell response against varicella-zoster virus in fingolimod-treated MS patients.
Overview of the biology of type I interferons.
Assessment of changes in immune measures of multiple sclerosis patients treated with laquinimod.
Epstein-Barr virus latent membrane protein 2A exacerbates experimental autoimmune encephalomyelitis and enhances antigen presentation function.
Microglia Induce Neurotoxic IL-17+ γδ T Cells Dependent on TLR2, TLR4, and TLR9 Activation.
Quantitative structure-activity relationship studies on sulfonamide-based MMP inhibitors.
Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis (EAE) Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge.
Social cognition in pediatric-onset multiple sclerosis (MS).
Laquinimod delays and suppresses nephritis in lupus-prone mice and affects both myeloid and lymphoid immune cells.
Longitudinal extensive transverse myelitis and optic neuritis: the elements for the diagnosis of neuromyelitis optica.
FDA approves first oral drug to reduce MS relapses
Using biomarkers to predict progression from clinically isolated syndrome to multiple sclerosis.
Fingolimod increases brain-derived neurotrophic factor levels and ameliorates amyloid β-induced memory impairment.

Pages